ArticleBMC infectious diseases2026
Joint impact of the number of comorbidities and the COVID-19 pandemic on the concordance of antibiotic prescriptions with clinical guidelines, in the community.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aimed to describe community antibiotic use for respiratory and urinary tract infections (UTIs), in Quebec, from 2018 to 2022 and to assess the joint effect of comorbidities and the COVID-19 pandemic on prescription concordance with provincial guidelines.
methodsA retrospective analysis was conducted using medical and pharmaceutical claims data from 2018 to 2022 for individuals insured by the public health and drug plans. Data were sourced from the Quebec Integrated Chronic Disease Surveillance System (QICDSS), linking five administrative databases. The primary outcome was the proportion of prescriptions concordant with the provincial guidelines for the most frequent infections in children and adults. Prescriptions dispensed within two days of a medical diagnosis for eligible infections were included. Robust Poisson regressions assessed the joint impact of number of comorbidities and pandemic period on concordance.
resultsIn children, over 90% of antibiotic prescriptions were concordant with guidelines. Lower concordance was observed for pneumonias and pharyngitis among children with comorbidities. In adults, concordance varied by infection type and declined with increasing comorbidities. Concordance improved during the pandemic and after for UTIs and rhinosinusitis, but decreased for pneumonias. No significant interactions were found between comorbidities and pandemic periods, except for bronchitis with chronic obstructive pulmonary disease (COPD).
conclusionIn Quebec, comorbidities were associated with decreased adherence to clinical guidelines for antibiotic prescribing, particularly among adults. The COVID-19 pandemic had minimal influence on concordance. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.